This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hiruma, M. Articles by Yamamoto, K. Search for Related Content PubMed PubMed Citation Articles by Hiruma, M. Articles by Yamamoto, K.

Hypertension, Vol 12, 317-323, Copyright © 1988 by American Heart Association

ARTICLES

Fate of recombinant human renin administered exogenously to anesthetized monkeys

M Hiruma, S Kim, F Ikemoto, K Murakami and K Yamamoto
Department of Pharmacology, Osaka City University, Medical School, Japan.

Highly purified recombinant human renin (rh-renin), synthesized by Chinese hamster ovary cells, was labeled with iodine-125 and was given intravenously to pentobarbital-anesthetized common marmosets (Callithrix jacchus) to study the fate of the circulating renin. Specific anti-rh-renin antiserum was used to identify the 125I-rh- renin. Plasma disappearance of the exogenously administered 125I-rh- renin in marmosets (n = 6) showed two exponential components, with a half-life of 12.1 +/- 1.9 minutes for the rapid component and 120.3 +/- 16.4 minutes for the slow component. The metabolic clearance rate was 1.17 +/- 0.26 ml/min/kg. Thirty minutes after the injection of 125I-rh- renin, 43.1 +/- 0.9 and 3.5 +/- 0.5% of the injected dose had distributed to the liver and the kidneys, respectively. With time, the accumulated 125I-rh-renin in the liver and kidneys decreased. The accumulation of 125I-rh-renin was less than 1% of the dose injected in other organs such as lungs, heart, spleen, adrenal glands, testes, and ovaries. Analysis of liver and kidney extracts by high performance liquid chromatography at 30 and 120 minutes indicated that immunoreactive 125I-rh-renin decreased with time and was accompanied by an increase in nonimmunoreactive degradation products of a low molecular weight. The incubation of 125I-rh-renin with monkey or human plasma at 37 degrees C did not degrade the labeled renin. Therefore, rh- renin was rapidly cleared from the circulation by the liver and the kidney.

This article has been cited by other articles:

				J. Bohlender, J. Menard, D. Ganten, and F. C. Luft Angiotensinogen Concentrations and Renin Clearance : Implications for Blood Pressure Regulation Hypertension, March 1, 2000; 35(3): 780 - 786. [Abstract] [Full Text] [PDF]

				A. H. J. Danser, C. A. M. van Kesteren, W. A. Bax, M. Tavenier, F. H. M. Derkx, P. R. Saxena, and M. A. D. H. Schalekamp Prorenin, Renin, Angiotensinogen, and Angiotensin-Converting Enzyme in Normal and Failing Human Hearts : Evidence for Renin Binding Circulation, July 1, 1997; 96(1): 220 - 226. [Abstract] [Full Text]

				W. G. Campbell Jr, F. Gahnem, D. F. Catanzaro, G. D. James, M. J. F. Camargo, J. H. Laragh, and J. E. Sealey Plasma and Renal Prorenin/Renin, Renin mRNA, and Blood Pressure in Dahl Salt-Sensitive and Salt-Resistant Rats Hypertension, May 1, 1996; 27(5): 1121 - 1133. [Abstract] [Full Text]